Price + Supply intelligence
When a drug is in shortage AND its price is rising, your hospital is exposed on two axes. VialWatch overlays Medicare Part B ASP price trends on top of FDA shortage status — so you see both pressures in one view.
FDA tells you what's in shortage. CMS publishes prices quarterly. Nobody puts them together — except us.
Pricing data composite-sourced from CMS Medicare Part B Average Sales Price (ASP) quarterly files. Reference per-unit price; actual hospital pricing varies by GPO contract. Updated as new ASP files are published.
Pro subscribers see ASP price trends on every drug they watchlist — alongside shortage status, recall flags, and supplier risk tiers. Make procurement decisions on cost AND supply, not one or the other.
View Pro pricing →